We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go: Stretch investment: Withheld
For Good Causes turn Loyalty points into donations for charities, giving people a new way to give to causes closest to their hearts. Brands are given a while new CSR opportunity and charities are given much-needed funding. Research has shown their is over £7bn unused rewards in the UK, values which could be donated.
days to go: Expired investment: £292,220
Wealthify is an online investment platform that lets you choose the parameters in which you want to invest such as; how much you want to invest, how long for and the risk level of the investment. 
days to go: Expired investment: £1,117,523
Total Be wants to bring an internationally recognised model of car insurance to the UK. It provides insurance for the car, not just for an individual driver. Additionally, it does not take crime data into account that is not specific to vehicles. Thus, this insurance is estimated to provide up to 25% cheaper cover in comparison to UK insurance. Moreover, a UK Government Petition for this insurance model has gained over 60,000+ signatures, which further validates the demand of this model. Total Be believes that it will be able to disrupt the UK market with this car insurance model.
days to go: Expired investment: £150,760
MarketsFlow is a London and Boston based, highly innovative and performance driven Investment Manager platform. It is authorised regulated by the FCA, FRN 792373 and SEC. The company supports its clients to achieve financial goals by helping their money grow. In 2019, MarketsFlow became the winner of the Best Programmatic Trading Technology at WSL and Fund in New York for the third year in a row. MarketsFlow offers Managed Portfolios (GIA), IRAs and ISAs. The company is expecting that its Growth and High Growth portfolio is accessible. In the coming months, the company is about to launch its new mobile application to complement its Growth using M&A deals.
days to go: Expired investment: £636,330
A financial management software application for consumers to view everything from credit files and bank accounts, to vouchers and cashbacks. Score Genius aims to launch an Alpha version of their product at the end of 2018, with a public release planned for March 2019. The service will offer users the ability to monitor their credit files and perform transactions on their bank accounts and credits, as Open Banking will be integrated into the platform. Score Genius is near completion of negotiations with large technological partners. Investments will used to market the platform and further develop features and functions, ready for the public release in 2019. Revenue streams will be comprised of advertisements, redeeming vouchers and users looking to switch their energy.
days to go: Expired investment: £144,920
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph